Has Cencora (COR) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.

The fact that multiple Cencora, Inc. (NYSE:COR) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. When analyzing insider ...

Cencora, Inc. (NYSE:COR – Free Report) – Stock analysts at Leerink Partnrs raised their FY2028 EPS estimates for shares of Cencora in a note issued to investors on Wednesday, April 2nd.

Shares of Cencora Inc. COR slid 1.38% to $274.56 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.23% to 5,062.25 and Dow ...

Alto and Cencora are collaborating to deliver enhanced patient support services and streamline access to prescribed specialty medications. The collaboration leverages Cencora’s patient support ...

Cencora COR has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table below ...

Cencora, Inc. (NYSE:COR – Get Free Report) reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as $280.70 and last traded at $278.17, with a volume of ...

Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2025 on Wednesday, May 7, 2025, prior to the opening of trading on the New York ...

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)-- Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2025 on Wednesday, May 7, 2025, prior to the ...